90 related articles for article (PubMed ID: 17661722)
1. Potential role of CREB as a prognostic marker in acute myeloid leukemia.
Cheng JC; Esparza S; Sandoval S; Shankar D; Fu C; Sakamoto KM
Future Oncol; 2007 Aug; 3(4):475-80. PubMed ID: 17661722
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclic AMP response element binding protein in human leukemias.
Shankar DB; Cheng JC; Sakamoto KM
Cancer; 2005 Nov; 104(9):1819-24. PubMed ID: 16196046
[TBL] [Abstract][Full Text] [Related]
3. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
[TBL] [Abstract][Full Text] [Related]
5. CREB: the unindicted cancer co-conspirator.
Conkright MD; Montminy M
Trends Cell Biol; 2005 Sep; 15(9):457-9. PubMed ID: 16084096
[TBL] [Abstract][Full Text] [Related]
6. CREB--a real culprit in oncogenesis.
Siu YT; Jin DY
FEBS J; 2007 Jul; 274(13):3224-32. PubMed ID: 17565603
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
[TBL] [Abstract][Full Text] [Related]
8. The role of CREB as a proto-oncogene in hematopoiesis.
Kinjo K; Sandoval S; Sakamoto KM; Shankar DB
Cell Cycle; 2005 Sep; 4(9):1134-5. PubMed ID: 16096372
[TBL] [Abstract][Full Text] [Related]
9. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
[TBL] [Abstract][Full Text] [Related]
10. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
[TBL] [Abstract][Full Text] [Related]
11. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.
Shankar DB; Cheng JC; Kinjo K; Federman N; Moore TB; Gill A; Rao NP; Landaw EM; Sakamoto KM
Cancer Cell; 2005 Apr; 7(4):351-62. PubMed ID: 15837624
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
13. Sox4 cooperates with CREB in myeloid transformation.
Sandoval S; Kraus C; Cho EC; Cho M; Bies J; Manara E; Accordi B; Landaw EM; Wolff L; Pigazzi M; Sakamoto KM
Blood; 2012 Jul; 120(1):155-65. PubMed ID: 22627767
[TBL] [Abstract][Full Text] [Related]
14. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin is expressed in normal and leukemic monocytes.
Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
[TBL] [Abstract][Full Text] [Related]
16. WT1 protein expression in childhood acute leukemia.
Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Apollon, an antiapoptotic protein, is associated with poor prognosis in childhood de novo acute myeloid leukemia.
Sung KW; Choi J; Hwang YK; Lee SJ; Kim HJ; Lee SH; Yoo KH; Jung HL; Koo HH
Clin Cancer Res; 2007 Sep; 13(17):5109-14. PubMed ID: 17785565
[TBL] [Abstract][Full Text] [Related]
18. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
19. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
